Summary & Overview
HCPCS A6022: Sterile Collagen Dressing, 16–48 sq in
HCPCS Level II code A6022 designates a sterile collagen dressing sized greater than 16 square inches and up to 48 square inches, billed per item. Advanced biologic dressings like this play a role in management of complex or chronic wounds, offering matrix support for tissue repair and potentially reducing dressing change frequency and resource use. Nationally, payers review these supplies for medical necessity, appropriate sizing, and documentation tied to wound assessment and skilled care.
Key payers covered in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find an overview of clinical context for collagen dressings, common sites of service where A6022 is used, and the payers commonly involved in coverage decisions. The publication summarizes benchmarking perspectives and policy topics relevant to billing and coverage for advanced wound care supplies. Where available, guidance on documentation expectations and coding practice for supply-level reporting is outlined. Data not available in the input is noted where specific payer coverage details, reimbursement benchmarks, and associated taxonomies or ICD-10 pairings were not provided.
Billing Code Overview
HCPCS Level II code A6022 describes a sterile collagen dressing with a size greater than 16 square inches and up to 48 square inches, billed per each dressing. The service type is wound care dressing application / supply. The typical site of service for this product is outpatient wound care settings, including hospital outpatient departments, ambulatory surgical centers, wound care clinics, home health visits, and other outpatient facilities where advanced dressings are applied or supplied.
Data not available in the input.
Clinical & Coding Specifications
Clinical Context
A typical patient is a 68-year-old with a chronic venous stasis ulcer on the lower leg that has failed to progress with standard moist wound care. The wound measures 30 square inches (greater than 16 sq. in. and less than or equal to 48 sq. in.) after debridement. The wound care nurse or podiatrist performs sharp or mechanical debridement at an outpatient wound clinic visit, documents wound measurements, infection status, and perfusion assessment, and then applies a sterile collagen dressing A6022 to promote granulation and provide a biologic scaffold. The dressing is secured with secondary dressings and the patient receives wound care education, a scheduled follow-up in 1 week for reassessment and dressing change, and orders for adjunctive therapy if indicated (compression for venous disease, offloading for pressure or diabetic ulcers). Typical workflow steps: wound assessment and measurement, cleansing and debridement as needed, selection and application of the A6022 collagen dressing, documentation of dressing size and lot number, application of secondary dressing, and scheduling of follow-up and any additional services.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
26 | Professional component | When billing separately for physician professional interpretation or services associated with wound evaluation if payer allows split billing |